English | 简体中文 | 繁體中文 | 한국어
Share:
Lubrizol Introduces Solsperse 74000 Hyperdispersant - Expands its Rad-Cure Dispersant Additive Portfolio for Printing Inks and Coatings
Lubrizol Introduces Solsperse 74000 Hyperdispersant - Expands its Rad-Cure Dispersant Additive Portfolio for Printing Inks and Coatings

  

CLEVELAND, March 15, 2017 - The Lubrizol Corporation introduces Solsperse(TM) 74000, a 100% solids wetting and dispersing agent for UV cured ink systems. Solsperse 74000 is a 100% active polymeric dispersant designed to improve operational efficiencies for both ink manufacturers and printers. Pigment concentrates and millbases made using Solsperse 74000 can achieve higher color strength at lower pigment loading, enabling higher print strength in final inks without compromising gloss, rheology or stability. These improvements are achieved across a wide range of pigments - both standard process and spot colors.

Solsperse 74000 is TSCA, DSL, REACh, Swiss Ordinance and Nestle compliant. It is APE-free1 and has no California Prop65 reportable content.

Contact Lubrizol to learn more about our full range of Solsperse high performance wetting and dispersing agents for UV cured inks and coatings.

About Lubrizol Performance Coatings

Lubrizol is a market-driven innovator of specialty chemicals that solve today's challenges in the paints and coatings, printing and packaging, paper and textiles, plastics and composites, and digital print markets. More than just a supplier, we are a partner with extensive experience in surface protection, dispersion, adhesion, and barrier properties that enables us to enhance the performance, simplicity, and eco-considerate benefits of our customers' products. With a commitment to collaboration, applied science, and demonstrated value, our team of experts is dedicated to exceeding customer expectations for both the simplest and toughest requirements. Count on Lubrizol to make the difference.

About The Lubrizol Corporation

The Lubrizol Corporation, a Berkshire Hathaway company, is a technology-driven global company that combines complex, specialty chemicals to optimize the quality, performance and value of customers' products while reducing their environmental impact. It produces and supplies technologies to customers in the global transportation, industrial and consumer markets. These technologies include lubricant additives for engine oils, driveline and other transportation-related fluids, industrial lubricants, as well as additives for gasoline and diesel fuel. In addition, Lubrizol makes ingredients and additives for home care and personal care products and specialty materials encompassing polymer and coatings technologies, along with polymer-based pharmaceutical and medical device solutions. Our products for the oilfield market include technologies for exploration, production and transportation.

With headquarters in Wickliffe, Ohio, Lubrizol owns and operates manufacturing facilities in 17 countries, as well as sales and technical offices around the world. Founded in 1928, Lubrizol has approximately 9,000 employees worldwide. Revenues for 2015 were $7 billion. For more information, visit Lubrizol.com.

Media Contact

Mike Heil

+1 (216) 447-5176

mike.heil@lubrizol.com

 

Website: https://www.lubrizol.com/coatings

 

1 APE not intentionally contained in the composition or used in manufacture of Solsperse(TM) 74000.

 





This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Lubrizol via Globenewswire

Copyright © Thomson Reuters 2018. All rights reserved.
Press Releases
Orion to sell its Orion Diagnostica division - Due to the transaction Orion updates its outlook  
Apr 21, 2018 00:30 ET
Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO® (fosnetupitant/ palonosetron) in the United States  
Apr 20, 2018 21:33 ET
BOURBON: Positive progress in negotiations with lenders  
Apr 20, 2018 18:30 ET
Hubbell Incorporated Declares Regular Quarterly Dividend  
Apr 20, 2018 16:01 ET
Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO® (fosnetupitant/ palonosetron) in the United States  
Apr 20, 2018 15:23 ET
Heineken Holding N.V. - Amendments to the Articles of Association  
Apr 20, 2018 15:18 ET
Lubrizol Presents Estane® TPU and Other Innovations for Consumer, Industrial, Footwear and Electronics Applications at Chinaplas 2018  
Apr 20, 2018 12:03 ET
Lipotec Active Ingredients Becomes Umbrella Brand  
Apr 19, 2018 23:43 ET
LEH PHARMA LTD.: Company Update  
Apr 18, 2018 19:34 ET
Tusk Therapeutics presents data on to its anti-CD25 programme at AACR Annual Meeting 2018  
Apr 18, 2018 19:33 ET
More News >>
Copyright © 2018 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: